Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significantly nn » significantly _ (Expand Search), significantly onto (Expand Search), significantly less (Expand Search)
significantly i » significantly _ (Expand Search), significantly high (Expand Search), significantly less (Expand Search)
Showing 2,861 - 2,880 results of 21,342 for search '(( ((significantly nn) OR (significantly i)) decrease ) OR ( significant decrease decrease ))', query time: 0.67s Refine Results
  1. 2861
    Changes in Mf (A and B) CFA (C and D) prevalence at baseline, 1, 2 and 3 years after starting MDA.

    Changes in Mf (A and B) CFA (C and D) prevalence at baseline, 1, 2 and 3 years after starting MDA. by Michael C. Payne (2664379)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2862
    Antimicrobial Activity of Glycyrrhizinic Acid Is pH-Dependent

    Antimicrobial Activity of Glycyrrhizinic Acid Is pH-Dependent by Mathieu Joos (20331128)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 2863
    Forest plot of the improvement in primary endpoints.

    Forest plot of the improvement in primary endpoints. by Jin-Min Gu (17915039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 2864
    Subgroup and sensitivity analyses for the primary outcomes.

    Subgroup and sensitivity analyses for the primary outcomes. by Jin-Min Gu (17915039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 2865
    Forest plot of inflammatory markers.

    Forest plot of inflammatory markers. by Jin-Min Gu (17915039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 2866
    Flow diagram for the identification of studies included.

    Flow diagram for the identification of studies included. by Jin-Min Gu (17915039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 2867
    Forest plot of the hospital stay length in distinct stages of patients.

    Forest plot of the hospital stay length in distinct stages of patients. by Jin-Min Gu (17915039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 2868
    Forest plot of the second endpoint of the clinical symptom improvement.

    Forest plot of the second endpoint of the clinical symptom improvement. by Jin-Min Gu (17915039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 2869
    Enrichment analysis of genes from the significant MS module.

    Enrichment analysis of genes from the significant MS module. by Lai Jiang (2401513)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 2870
    Results of cost-effectiveness analysis of <i>Chuna</i> manual therapy compared with usual care<sup>a</sup>.

    Results of cost-effectiveness analysis of <i>Chuna</i> manual therapy compared with usual care<sup>a</sup>. by Jae-Heung Cho (798319)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 2871
    Main baseline characteristics of patients included in the study.

    Main baseline characteristics of patients included in the study. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 2872
    (A) Monthly drug costs of patients in the ESAs group and Roxadustat group.

    (A) Monthly drug costs of patients in the ESAs group and Roxadustat group. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 2873
    Study data.

    Study data. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 2874
    Mean hemoglobin levels of Roxadustat and ESAs groups over time.

    Mean hemoglobin levels of Roxadustat and ESAs groups over time. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 2875
    Morisky score for ESAs group and Roxadustat group.

    Morisky score for ESAs group and Roxadustat group. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 2876
    Patient flow diagram.

    Patient flow diagram. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 2877
    Mean total cholesterol levels over time in the roxadustat group (A) and ESAs group (B) according to the statins subgroup.

    Mean total cholesterol levels over time in the roxadustat group (A) and ESAs group (B) according to the statins subgroup. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 2878
    Summary of clinical outcomes after 9 months.

    Summary of clinical outcomes after 9 months. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 2879
    Approval by the research ethics committee.

    Approval by the research ethics committee. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 2880
    (A) Changes of left ventricular ejection fraction over time in Roxadustat and ESAs groups.

    (A) Changes of left ventricular ejection fraction over time in Roxadustat and ESAs groups. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: